Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors

Details for Australian Patent Application No. 2010247835 (hide)

Owner EnVivo Pharmaceuticals, Inc.

Inventors Koenig, Gerhard; Hilt, Dana

Agent Spruson & Ferguson

Pub. Number AU-A-2010247835

PCT Pub. Number WO2010/132423

Priority 61/177,260 11.05.09 US

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 31/27 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/132423 Priority application(s): WO2010/132423

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247839-Enteral connectors and systems

2010247832-Improved recliner ottoman linkage with unique secondary ottoman